Ribonucleic Acid (RNA) Markers Market Growth Accelerated by Rising Application in Diagnostic Laboratories

 

Ribonucleic acid (RNA) markers play a crucial role in understanding disease mechanisms and diagnosis applications. RNA sequencing helps in analyzing transcriptomic changes and assists in disease diagnosis, patient stratification, and monitoring treatment response. The global Ribonucleic Acid (RNA) Markers Market is estimated to be valued at US$ 347.6 Mn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising application of RNA markers in diagnostic laboratories is one of the major trends contributing to the growth of RNA markers market. Due to RNA’s significant role in biological pathways and pathogenic processes, its analysis can aid in disease diagnosis and disease classification. RNA markers find widespread use in areas such as oncology, infectious diseases, neurological disorders among others. With increasing burden of diseases and demand for precise diagnostic techniques, the use of RNA markers in laboratories is growing steadily which in turn is fueling the market growth over the forecast period.

Segment Analysis
The global Ribonucleic Acid (RNA) Markers market is segmented based on type, technology, application, and end-user. The type segment is further bifurcated into DNA markers and RNA markers. Among these, the RNA markers segment dominated the market in 2022 owing to rising demand for RNA-based techniques for gene expression analysis. RNA markers allow direct interrogation of the expressed genome.

Key Takeaways
The global Ribonucleic Acid (RNA) Markers market is expected to witness high growth over the forecast period.

Regional Analysis: North America held the largest share of the global RNA market in 2022 due to high adoption of advanced technologies for clinical research. It is expected to remain the dominant regional market owing to significant funding for genomics research and the presence of key market players in the region.

Key players operating in the Ribonucleic Acid (RNA) Markers market are Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Qiagen, Illumina, Promega Corporation, New England Biolabs, and Takara Bio. Thermo Fisher Scientific is a leading provider of RNA markers with a wide range of product offerings.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more